Published in Drug Law Weekly, October 13th, 2009
"Using M protein mutant vesicular stomatitis virus(Delta M51-VSV) as a gene-delivery vector, we demonstrate that a high level of transgene expression could be achieved in similar to 70% of DCs without affecting cell viability. Furthermore, Delta M51-DCs infection activated DCs to produce...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.